News

All news

CSR Events General PERSONAL CARE Press release Products & Technologies Protéus

SEQENS announces the appointement of a new CEO

France-based SEQENS, a leader in the development and production of active pharmaceutical ingredients, pharmaceutical intermediates, and specialty ingredients, announces that Pascal Villemagne has been named Chief Executive Officer, effective 1st April 2025. Pascal brings a wealth of experience to the role, having previously served as CEO of CARBOGEN AMCIS, a company specializing in the manufacture … Continued

Read more

Eurazeo announces that it has entered into exclusive discussions to sell its stake in SEQENS

Labcom HitCat Inauguration in partnership with the CNRS

France Relance program: SEQENS new paracetamol production unit

Seqens is proud to announce the official partnership between Alganelle and Sederma for the development of a future cosmetic ingredient.

Biocatalysis: a science in permanent technological evolution

Protéus by Seqens, expertise partner of the virtual congress Protein Engineering Connect

Seqens supports the French Business Climate Pledge initiative

Essential molecules’ production in France: our investment plan

Seqens’ commitment to reducing its carbon footprint

Nitrosamines: quick mobilization of a multidisciplinary team in response to regulatory changes

Our products contribute to the 17 United Nations SDGs

Improving customer service: a challenge for SEQENS group

1 2 3 4 5 6 7

Contact